Scientists at the WHO have provided a major boost to the UK government’s vaccine strategy on two major fronts; approving both the Oxford/AstraZeneca vaccine for use in all adults – including those over 65 – and backing the single-dose strategy with an 8-12 week gap, saying it is “associated with greater vaccine efficacy”. Read the recommendations in full below: